<SEC-DOCUMENT>0001683168-18-003156-index.html : 20181026
<SEC-HEADER>0001683168-18-003156.hdr.sgml : 20181026
<ACCEPTANCE-DATETIME>20181026151625
ACCESSION NUMBER:		0001683168-18-003156
CONFORMED SUBMISSION TYPE:	1-A/A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20181026
DATE AS OF CHANGE:		20181026

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CNS Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001729427
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				822318545
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		1-A/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	024-10855
		FILM NUMBER:		181141509

	BUSINESS ADDRESS:	
		STREET 1:		2100 WEST LOOP SOUTH
		STREET 2:		SUITE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027
		BUSINESS PHONE:		1-800-946-9185 X701

	MAIL ADDRESS:	
		STREET 1:		2100 WEST LOOP SOUTH
		STREET 2:		SUITE 900
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77027
</SEC-HEADER>
<DOCUMENT>
<TYPE>1-A/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>PART II AND III
<SEQUENCE>2
<FILENAME>cns_1aa3.htm
<DESCRIPTION>POC AMEND NO. 3
<TEXT>
Document 2 - file: cns_1aa3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX1A-9 ACCT LTR
<SEQUENCE>3
<FILENAME>cns_1aa3-ex0901.htm
<DESCRIPTION>ACCOUNTING LETTER
<TEXT>
Document 3 - file: cns_1aa3-ex0901.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX1A-12 OPN CNSL
<SEQUENCE>4
<FILENAME>cns_1aa3-ex1201.htm
<DESCRIPTION>OPINION
<TEXT>
Document 4 - file: cns_1aa3-ex1201.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>